Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report
OncoSil Medical presented updated results from its TRIPP-FFX study at ESMO GI 2026, the European Society for Medical Oncology's Gastrointestinal Cancers Congress, held in Munich, Germany. According to the company, the data were delivered on 6 July 2026 as a Rapid Oral Presentation by …
With a market capitalisation of approximately AUD 9.77 billion, Ramsay Health Care Ltd is among the companies reflected in the S&P/ASX 200 Health Care Index, which tracks major healthcare-related businesses listed on the Australian Securities Exchange.
With a market capitalisation of approximately AUD 16.36 billion, ResMed Inc is among the companies reflected in the S&P/ASX 200 Health Care Index, which tracks major healthcare-related businesses listed on the Australian Securities Exchange.
With a market capitalisation of approximately AUD 1.90 billion, Ryman Healthcare Ltd is among the companies reflected in the S&P/ASX 200 Health Care Index, which tracks major healthcare-related businesses listed on the Australian Securities Exchange.
With a market capitalisation of approximately AUD 33.13 billion, Sigma Healthcare Ltd is among the companies reflected in the S&P/ASX 200 Health Care Index, which tracks major healthcare-related businesses listed on the Australian Securities Exchange.
With a market capitalisation of approximately AUD 5.15 billion, TELIX Pharmaceuticals Ltd is among the companies reflected in the S&P/ASX 200 Health Care Index, which tracks major healthcare-related businesses listed on the Australian Securities Exchange.
With a market capitalisation of approximately AUD 2.09 billion, Neuren Pharmaceuticals Ltd is among the companies reflected in the S&P/ASX 200 Health Care Index, which tracks major healthcare-related businesses listed on the Australian Securities Exchange.
With a market capitalisation of approximately AUD 16.94 billion, Pro Medicus Ltd is among the companies reflected in the S&P/ASX 200 Health Care Index, which tracks major healthcare-related businesses listed on the Australian Securities Exchange.
With a market capitalisation of approximately AUD 639.03 million, Polynovo Ltd is among the companies reflected in the S&P/ASX 200 Health Care Index, which tracks major healthcare-related businesses listed on the Australian Securities Exchange.
With a market capitalisation of approximately AUD 1.65 billion, PYC Therapeutics Ltd is among the companies reflected in the S&P/ASX 200 Health Care Index, which tracks major healthcare-related businesses listed on the Australian Securities Exchange.
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Start Your 7-Days Free Trial Today!
Hi! How can we help you today?
Loading…